药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Clonitazene
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Pilsicainide.
Clonitazene
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Pilsicainide.
Clonitazene
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Pilsicainide.
Clonitazene
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Pilsicainide.
Clonitazene
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Pilsicainide.
Clonitazene
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Pilsicainide.
Clonitazene
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Pilsicainide.
Clonitazene
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Pilsicainide.
Clonitazene
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Pilsicainide.
Clonitazene
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Pilsicainide.
Clonitazene
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Pilsicainide.
Clonitazene
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Pilsicainide.
Clonitazene
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Pilsicainide.
Clonitazene
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Pilsicainide.
Clonitazene
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Pilsicainide.
Clonitazene
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Pilsicainide.
Clonitazene
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Pilsicainide.
Clonitazene
Delamanid
Pilsicainide may increase the QTc-prolonging activities of Delamanid.
Clonitazene
Macimorelin
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Macimorelin.
Clonitazene
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Deutetrabenazine.